Counselors in Secane, PA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Mr. Darin Lamar Hudson, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 914 South Ave Apt H28, Secane, PA 19018 Phone: 267-449-1624 |
Pete J Bendig Jr., PHD/ABD, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 953 Dale Rd, Secane, PA 19018 Phone: 484-472-7530 Fax: 484-472-7530 |
 Chanel Y Grundy, MS, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 914 South Ave Apt C19, Secane, PA 19018 Phone: 484-206-5044 |
News Archive
Women with recurrent ovarian cancer survive longer after treatment with cediranib
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress.
Scientists provide the first comprehensive picture of minimal cell
What are the bare essentials of life, the indispensable ingredients required to produce a cell that can survive on its own? Can we describe the molecular anatomy of a cell, and understand how an entire organism functions as a system? These are just some of the questions that scientists in a partnership between the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and the Centre de Regulacio Genòmica (CRG) in Barcelona, Spain, set out to address.
UN reports that more needs to be done so all children are born HIV and syphilis free in Asia-Pacific region
The Asia–Pacific region has made significant progress in efforts to eliminate HIV and syphilis, but thousands of mothers and children have yet to feel the benefits.
Merck's TREDAPTIVE clinical study on high-risk CVD patients does not meet primary endpoint
Merck, known outside the United States and Canada as MSD, today announced that the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events) study of TREDAPTIVE(extended-release niacin/laropiprant) did not meet its primary endpoint.
› Verified 3 days ago